JP2004534850A5 - - Google Patents

Download PDF

Info

Publication number
JP2004534850A5
JP2004534850A5 JP2003512363A JP2003512363A JP2004534850A5 JP 2004534850 A5 JP2004534850 A5 JP 2004534850A5 JP 2003512363 A JP2003512363 A JP 2003512363A JP 2003512363 A JP2003512363 A JP 2003512363A JP 2004534850 A5 JP2004534850 A5 JP 2004534850A5
Authority
JP
Japan
Prior art keywords
compound according
compound
phe
optionally substituted
phenylalanyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003512363A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004534850A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/021443 external-priority patent/WO2003006604A2/en
Publication of JP2004534850A publication Critical patent/JP2004534850A/ja
Publication of JP2004534850A5 publication Critical patent/JP2004534850A5/ja
Withdrawn legal-status Critical Current

Links

JP2003512363A 2001-07-12 2002-07-08 強力な選択的メラノコルチン−4受容体アゴニストとしての環状ペプチド Withdrawn JP2004534850A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30495801P 2001-07-12 2001-07-12
PCT/US2002/021443 WO2003006604A2 (en) 2001-07-12 2002-07-08 Cyclic peptides as potent and selective melanocortin-4 receptor agonists

Publications (2)

Publication Number Publication Date
JP2004534850A JP2004534850A (ja) 2004-11-18
JP2004534850A5 true JP2004534850A5 (https=) 2005-12-22

Family

ID=23178678

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003512363A Withdrawn JP2004534850A (ja) 2001-07-12 2002-07-08 強力な選択的メラノコルチン−4受容体アゴニストとしての環状ペプチド

Country Status (5)

Country Link
US (1) US6960646B2 (https=)
EP (1) EP1409521A2 (https=)
JP (1) JP2004534850A (https=)
CA (1) CA2453027A1 (https=)
WO (1) WO2003006604A2 (https=)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7176279B2 (en) 2000-06-28 2007-02-13 Palatin Technologies, Inc. Cyclic peptide compositions and methods for treatment of sexual dysfunction
EP1441750A4 (en) 2001-07-11 2006-10-18 Palatin Technologies Inc LINEAR AND CYCLIC PEPTIDES SPECIFIC TO THE MELANOCORTIN RECEPTOR
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
KR20060026011A (ko) 2003-05-09 2006-03-22 노보 노르디스크 에이/에스 비만 치료용 펩티드
EP1644023A2 (en) * 2003-06-19 2006-04-12 Eli Lilly And Company Melanocortin recptor 4(mc4) agonists and their uses
EP1644022A1 (en) * 2003-06-19 2006-04-12 Eli Lilly And Company Uses of melanocortin-3 receptor (mc3r) agonist peptides
WO2005060985A1 (en) * 2003-12-10 2005-07-07 Merck & Co., Inc. Inhibition of voluntary ethanol consumption with selective melanocortin 4-receptor agonists
JP2007530674A (ja) * 2004-03-29 2007-11-01 イーライ リリー アンド カンパニー 連続注入によって投与されるメラノコルチン−4受容体(mc4r)アゴニストペプチドの使用
EP1734963A4 (en) 2004-04-02 2008-06-18 Merck & Co Inc METHOD FOR TREATING PEOPLE WITH METABOLIC AND ANTHROPOMETRIC DISORDER
CN101203527A (zh) * 2005-05-31 2008-06-18 耶路撒冷希伯来大学伊森姆研究发展公司 主链环化的促黑皮质素激素(αMSH)类似物
US20070021433A1 (en) 2005-06-03 2007-01-25 Jian-Qiang Fan Pharmacological chaperones for treating obesity
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
KR101687037B1 (ko) 2008-06-09 2016-12-15 팔라틴 테크놀로지스 인코포레이티드 성기능 장애 치료용 멜라노코르틴 수용체-특이적 펩티드
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
EP2348857B1 (en) 2008-10-22 2016-02-24 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
US8329914B2 (en) 2008-10-31 2012-12-11 Merck Sharp & Dohme Corp Cyclic benzimidazole derivatives useful as anti-diabetic agents
CA2761607C (en) 2009-06-08 2018-09-04 Yi-Qun Shi Melanocortin receptor-specific peptides
EP2440572B1 (en) 2009-06-08 2017-04-05 Palatin Technologies, Inc. Lactam-bridged melanocortin receptor-specific peptides
UY32690A (es) 2009-06-08 2011-01-31 Astrazeneca Ab Péptidos específicos para receptores de melanocortina
BR112012011780A2 (pt) 2009-11-23 2019-09-24 Palatin Technologies, Inc peptídeo linear,composição farmacêutica,métodopara tratamento de umadoença,indicação,condição ou sídrome mediadsa por receptor de melanocortina emum mamífero humano ou não humano e método para tratamento de uma condição responsiva ás alterações em função de receptor de melanocortina em um mamifero humano ou não humano
JP5999702B2 (ja) 2009-11-23 2016-09-28 パラティン テクノロジーズ, インコーポレイテッドPalatin Technologies, Inc. メラノコルチン−1受容体特異的環状ペプチド
JP2013520502A (ja) 2010-02-25 2013-06-06 メルク・シャープ・エンド・ドーム・コーポレイション 有用な抗糖尿病薬である新規な環状ベンズイミダゾール誘導体
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
SG192941A1 (en) 2011-02-25 2013-09-30 Merck Sharp & Dohme Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
RU2015106909A (ru) 2012-08-02 2016-09-27 Мерк Шарп И Доум Корп. Антидиабетические трициклические соединения
KR20150118158A (ko) 2013-02-22 2015-10-21 머크 샤프 앤드 돔 코포레이션 항당뇨병 비시클릭 화합물
WO2014139388A1 (en) 2013-03-14 2014-09-18 Merck Sharp & Dohme Corp. Novel indole derivatives useful as anti-diabetic agents
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
BR112015030326A2 (pt) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
WO2015051496A1 (en) 2013-10-08 2015-04-16 Merck Sharp & Dohme Corp. Antidiabetic tricyclic compounds
US10899793B2 (en) 2016-05-27 2021-01-26 Regents Of The University Of Minnesota Melanocortin ligands and methods of use thereof
US11124541B2 (en) 2016-10-18 2021-09-21 Regents Of The University Of Minnesota Chimeric melanocortin ligands and methods of use thereof
US11072602B2 (en) 2016-12-06 2021-07-27 Merck Sharp & Dohme Corp. Antidiabetic heterocyclic compounds
EP3558298B1 (en) 2016-12-20 2026-03-11 Merck Sharp & Dohme LLC Antidiabetic spirochroman compounds
US11332499B2 (en) 2018-08-16 2022-05-17 Regents Of The University Of Minnesota Cyclic peptides and methods of use thereof
US11590209B2 (en) 2020-01-21 2023-02-28 Palatin Technologies, Inc. Use of bremelanotide in patients with controlled hypertension

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622860A (en) * 1994-02-17 1997-04-22 The Regents Of The University Of Michigan Genes encoding melanocortin receptors
US6054556A (en) * 1995-04-10 2000-04-25 The Arizona Board Of Regents On Behalf Of The University Of Arizona Melanocortin receptor antagonists and agonists
CA2251520C (en) * 1997-10-31 2003-12-30 Honda Giken Kogyo Kabushiki Kaisha Pipe connector connection checking assembly
SI1315750T1 (sl) 2000-08-30 2007-06-30 Hoffmann La Roche Cikliäśni peptidi kot agonisti za receptorje melanokortina-4

Similar Documents

Publication Publication Date Title
JP2004534850A5 (https=)
JP2013507439A5 (https=)
MY136034A (en) New medicaments for the treatment of chronic obstructive pulmonary disease
JP2020097577A5 (https=)
JP2005537234A5 (https=)
CY1115719T1 (el) Νεοι φαρμακευτικοι συνδυασμοι για τη θεραπεια νοσων των αναπνευστικων οδων
EP2573079A3 (en) Benzimidazole quinolinones and uses thereof
NZ522326A (en) Adenosine A2A receptor antagonists
JP2006182786A5 (https=)
JP2011528713A5 (https=)
JP2009535352A5 (https=)
EP2036902A3 (en) Urea compounds active as vanilloid receptor antagonist for the treatment of pain
MXPA04001500A (es) Compuestos que tienen un efecto sobre la glucocinasa.
JP2006514012A5 (https=)
IL170120A (en) 4,2,1 - Triazines, their use in the preparation of HIV treatment or prophylaxis drugs, containing pharmaceutical preparations and methods for their preparation
JP2019515908A5 (https=)
JP2007537301A5 (https=)
JP2011505356A5 (https=)
JP2008513510A5 (https=)
JP2006514116A5 (https=)
JP2004502755A5 (https=)
JP2010500284A5 (https=)
TW200531688A (en) Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
JP2012523416A5 (https=)
JP2005513036A5 (https=)